Director Phyllis Gardner sold $168K of Revance Therapeutics, Inc.

Sold$168,045

$31.51Price

5,333Shares

−64%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Fri, Mar 16. Filed Fri, Mar 16, 4:35 PM ET, after the close. Not investment advice.